What we do
TranspariMED works to end evidence distortion in medicine.
Failure to register and fully report clinical trials harms patients, wastes taxpayers' money, and slows down the development of new treatments, vaccines and cures.
TranspariMED uses research-driven advocacy to develop and promote policy solutions to this ongoing public health crisis.
Till Bruckner
Warning: Transparency and accountability nerd
-> Founder of TranspariMED
-> Advocacy manager with Transparify
Formerly with AllTrials and Transparency International.
Support us
TranspariMED relies on support from people like you to keep up the good fight.
We are close to the finishing line.
Please donate so we can fix this problem, once and for all
Collaborating Groups
Past and present collaborators include:
-
Collaboration for Research Integrity and Transparency at Yale Law School (CRIT)
-
Stichting Farma ter Verantwoording (Pharmaceutical Accountability Foundation)
TranspariMED often collaborates with other nonprofits on issues of common interest.
TranspariMED is a partner of Consilium Scientific and a member of the European Alliance for Responsible R&D and Affordable Medicines.
Who funds TranspariMED?
Set up in March 2017 by transparency campaigner Till Bruckner, TranspariMED between 2017 and 2021 received external funding (less than £30,000 total) exclusively via individual research grants provided to its founder by HealthSense (formerly HealthWatch), a UK registered charity. Since January 2022, Till Bruckner is receiving a monthly partnership stipend from the UK-based nonprofit Consilium Scientific. TranspariMED's work is further cross-subsidized through the consulting work of its founder (no pharma or medical device clients) and income from a part-time research followship at the QUEST Center for Responsible Research in Berlin (ends March 2022). Any future funding will be promptly and fully disclosed on this website.